Recombinant human ZRSR2 protein; Source: E. coli derived, PGEX-4T; Tag: GST; Domain: 360-482 aa of BC050451
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:500-1:3000
General Notes
This product (Catalog No. DPABH-13389) is a rabbit-derived polyclonal antibody raised against human ZRSR2, targeting the amino acid region 360–482 of the protein. It has been affinity purified by Protein A. ZRSR2 is an essential splicing factor. The protein associates with the U2 auxiliary factor heterodimer, which is required for the recognition of a functional 3 splice site in pre-mRNA splicing, and may play a role in network interactions during spliceosome assembly. This gene encodes U2AF small subunit related protein 2 which is an essential splicing factor. This protein is associated with the U2AF heterodimer composed of a large and a small subunit. It specifically interacts with the large subunit through an U2AF small subunit homologous region, and with SR proteins through its RS domain. This protein and U2AF small subunit are not functionally redundant. DPABH-13389 is suitable for use in Western blot (WB) (1:500–1:3,000) application. DPABH-13389 is supplied as a liquid formulation in PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
Renal carcinoma antigen NY-REN-20; U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2; U2(RNU2) small nuclear RNA auxiliary factor 1-like 2; U2AF1L2; U2AF1RS2
My Review for Rabbit Anti-Human ZRSR2 (a.a. 360-482) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.